Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at PLN 347.5B, ahead of Johnson & Johnson (PLN 327.7B) and Sanofi (PLN 318.3B). Figures as of 18 Nov 2026, 13:42 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerPLN 347.5B
- Median
- PLN 3.5B
- Combined market value
- PLN 20.73T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | PLN 347.5B | PLN 652.2B | PLN 114.42 | 1.35% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | PLN 327.7B | PLN 2.7T | PLN 1,120.04 | 1.36% down | 38% up | ||
| 3 | SanofiSNY · Health Care | PLN 318.3B | PLN 458.7B | PLN 191.01 | 1.78% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | PLN 211.4B | PLN 1.42T | PLN 576.18 | 0.75% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | PLN 209.5B | PLN 728.8B | PLN 420.81 | 2.55% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | PLN 195.6B | PLN 1.14T | PLN 732.51 | 0.95% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | PLN 187B | PLN 277.9B | PLN 86.97 | 0.23% up | 54% up | ||
| 8 | NovartisNVS · Health Care | PLN 185.4B | PLN 1.21T | PLN 639.51 | 0.67% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | PLN 125.6B | PLN 398.2B | PLN 3,849.05 | 0.56% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | PLN 115.7B | PLN 720.9B | PLN 163.57 | 2.16% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | PLN 106.6B | PLN 5.07T | PLN 5,688.81 | 1.13% down | 35% up | ||
| 12 | GSKGSK · Health Care | PLN 87.4B | PLN 396.7B | PLN 197.89 | 2.32% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | PLN 75B | PLN 544.3B | PLN 2,146.84 | 0.67% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | PLN 74.2B | PLN 504B | PLN 246.55 | 2.51% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | PLN 59.1B | PLN 94.2B | PLN 82.18 | 1.40% down | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | PLN 39B | PLN 158.7B | PLN 276.01 | 0.23% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 31.8B | PLN 199.9B | PLN 171.28 | 0.12% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | PLN 28.5B | PLN 100B | PLN 2,347.38 | 0.64% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | PLN 26.3B | PLN 51.9B | PLN 103.89 | 2.12% down | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | PLN 24.5B | PLN 45.5B | PLN 235.14 | 0.90% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | PLN 23.5B | PLN 23.6B | PLN 34.68 | 1.15% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | PLN 23.5B | PLN 128.8B | PLN 208.82 | 0.76% up | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | PLN 18.2B | PLN 112.7B | PLN 155.57 | 0.26% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | PLN 17.5B | PLN 189.7B | PLN 1,660.81 | 0.48% up | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 17.4B | PLN 62.1B | PLN 967.37 | 0.39% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 16.1B | PLN 49.6B | PLN 59.44 | 0.61% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | PLN 13.4B | PLN 136.3B | PLN 335.49 | 1.08% down | 29% down | ||
| 28 | AlkermesALKS · Health Care | PLN 7.3B | PLN 30.7B | PLN 182.65 | 2.32% down | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | PLN 4.1B | PLN 23.6B | PLN 1,180.76 | 2.62% down | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | PLN 4B | PLN 12.6B | PLN 64.74 | 0.75% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.5B | PLN 34.3B | PLN 1,225.98 | 1.68% down | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | PLN 3.2B | PLN 84.2B | PLN 628.94 | 2.02% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.7B | PLN 633.85 | 2.98% down | 31% up | ||
| 34 | InsmedINSM · Health Care | PLN 3B | PLN 107.4B | PLN 489.73 | 0.83% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | PLN 2.9B | PLN 35.8B | PLN 377.00 | 5.60% down | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | PLN 2.6B | PLN 34.3B | PLN 42.88 | 9.73% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | PLN 2.6B | PLN 38.1B | PLN 252.02 | 0.08% down | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | PLN 2.6B | PLN 30.8B | PLN 281.60 | 1.23% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | PLN 2.6B | PLN 19.5B | PLN 111.92 | 1.49% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.5B | PLN 32.7B | PLN 501.02 | 0.13% down | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.4B | PLN 39.4B | PLN 1,695.89 | 0.46% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 2.3B | PLN 30B | PLN 382.23 | 0.93% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.1B | PLN 18.5B | PLN 168.95 | 3.75% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | PLN 2B | PLN 28.9B | PLN 329.94 | 1.81% down | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | PLN 2B | PLN 19.7B | PLN 349.56 | 2.87% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | PLN 2B | PLN 18B | PLN 108.35 | 3.75% down | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | PLN 1.9B | PLN 26.3B | PLN 387.09 | 2.94% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 1.9B | PLN 24.4B | PLN 172.77 | 2.76% down | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | PLN 1.3B | PLN 16.2B | PLN 118.07 | 2.59% down | 169% up | ||
| 50 | ErascaERAS · Health Care | PLN 1.3B | PLN 19.6B | PLN 55.82 | 8.07% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | PLN 1.3B | PLN 24.1B | PLN 369.53 | 0.40% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 558.9M | PLN 32.5B | PLN 468.63 | 8.49% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | PLN 461.5M | PLN 19.7B | PLN 205.36 | 2.82% up | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | PLN 354.8M | PLN 28.7B | PLN 546.36 | 0.77% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -PLN 284.5M | PLN 29.6B | PLN 84.88 | 0.52% down | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -PLN 486.3M | PLN 21.3B | PLN 504.92 | 1.88% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -PLN 726M | PLN 71.5B | PLN 1,089.86 | 0.20% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -PLN 825.1M | PLN 20.3B | PLN 242.57 | 1.00% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -PLN 2.7B | PLN 28.9B | PLN 207.57 | 2.86% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -PLN 8.4B | PLN 60.1B | PLN 308.64 | 0.72% down | 17% up | ||
| 61 | AbbVieABBV · Health Care | -PLN 13.1B | PLN 2.08T | PLN 1,176.79 | 0.59% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0188 PLN).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (PLN 347.5B), Johnson & Johnson (PLN 327.7B) and Sanofi (PLN 318.3B) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 13:42 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of PLN 20.73T as of 18 Nov 2026, 13:42 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.